Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-920

5 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 51655-920). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of Atorvastatin Calcium, showing the molecular arrangement including calcium ions and the atorvastatin moiety.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line chart showing cumulative incidence (%) over time in years comparing Atorvastatin and Placebo groups. The solid line represents Atorvastatin and the dashed line represents Placebo, with Atorvastatin showing a lower cumulative incidence. The chart includes a hazard ratio (HR) of 0.64 with confidence interval (0.50-0.83) and a p-value of 0.0005.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph comparing cumulative hazard percentages over time between placebo and atorvastatin groups. The x-axis represents time in years up to 5 years, and the y-axis shows cumulative hazard percentage. The atorvastatin group shows a lower cumulative hazard compared to placebo, with hazard ratio and p-value indicated.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line chart comparing the percentage of subjects experiencing a major cardiovascular event over time for two atorvastatin doses, 10 mg and 80 mg. The x-axis represents time to first major cardiovascular endpoint in years (0 to 5), and the y-axis shows the percentage of subjects experiencing the event. The 10 mg group shows a higher event rate than the 80 mg group, with a hazard ratio (HR) of 0.78 (95% CI 0.69-0.89) and a p-value of 0.0002.*
FDA Label Image

Label (51655 920 83 Rev B 05 24 Nhc)

Label (51655 920 83 Rev B 05 24 Nhc)
Label for Atorvastatin Calcium Tablets USP 20 mg by Northwind Health Company, LLC. The label indicates prescription only (Rx only), a package containing 180 film-coated tablets for oral use, storage instructions, and controlled room temperature guidelines. The NDC is 51655-920-83.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.